Crohn’s Disease and SLC11A1 Promoter Polymorphism

@article{Chermesh2006CrohnsDA,
  title={Crohn’s Disease and SLC11A1 Promoter Polymorphism},
  author={Irit Chermesh and Aviva Azriel and Michal Alter-Koltunoff and R. Eliakim and Amir Karban and Ben-Zion Levi},
  journal={Digestive Diseases and Sciences},
  year={2006},
  volume={52},
  pages={1632-1635}
}
Crohn’s disease (CD) is a chronic multifactorial inflammatory disease. The prevalence of CD in Ashkenazi Jews is higher than in Sephardic Jews. SLC11A1, also known as Nramp1, is a divalent cation antiporter essential for the elimination of intraphagosomal pathogens. SLC11A1 has seven alleles in the promoter region and previous studies have suggested an association between CD and SLC11A1. The aim of this study was to check for a possible association between SLC11A1 promoter alleles and CD in… 
Role of functional polymorphisms of NRAMP1 gene for the development of Crohn's disease
TLDR
It is speculated that overrepresentation of allele 3 in CD patients could lead to hyperactivation of bowel‐wall macrophages that are chronically exposed to lipopolysaccharide and this could subsequently cause the autoimmune‐like phenotype characteristic of CD.
Population‐based case‐control study of alpha 1‐antitrypsin and SLC11A1 in Crohn's disease and ulcerative colitis
Background: Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory diseases of the digestive tract. Genetic factors and an abnormal immune response to infections are suspected to
Associations between NRAMP1 Polymorphisms and Susceptibility to Ulcerative Colitis/Crohn’s Disease: A Meta-Analysis
TLDR
The polymorphism of −237 C/T is related to the risk of CD; and the association of allele 3 with UC/CD risk differs in Caucasian and non-Caucasian population, which might be the potential biomarkers for clinical diagnosis of UC/ CD.
The Paratuberculosis Paradigm Examined: A Review of Host Genetic Resistance and Innate Immune Fitness in Mycobacterium avium subsp. Paratuberculosis Infection
TLDR
Evidence supporting the vital role of these genes in MAP infection outcome, associated challenges, and implications for the future of JD research are highlighted.
Crohn’s disease and the mycobacterioses: A quarter century later. Causation or simple association?
TLDR
This review is an attempt to provide a thorough and objective summary of current knowledge from both basic and clinical research from the views and interpretations of both the antagonists and proponents of M. paratuberculosis in Crohn’s disease.
Inflammatory bowel diseases: current therapeutic approaches and potential of using stem cells
TLDR
Current therapies for IBDs and recent advances in the field of stem cell therapy, which offer promise to become the next generation treatment of choice are summarized.

References

SHOWING 1-10 OF 27 REFERENCES
NOD2/CARD15 Genotype and Phenotype Differences between Ashkenazi and Sephardic Jews with Crohn's Disease
TLDR
It is suggested that NOD2/CARD15 mutations could contribute to the higher incidence and prevalence rates of CD among Ashkenazi Jews because of the high rates of smoking, family history of inflammatory bowel diseases, and extraintestinal manifestations among Sephardic CD patients.
Association between mutations in the CARD15 (NOD2) gene and Crohn's disease in Israeli Jewish patients
TLDR
It is concluded that germline mutations in the CARD15 gene are more frequently found in CD than UC patients and appear to predict an earlier age‐of‐onset in Ashkenazi Jewish patients.
Evaluation of SLC11A1 as an inflammatory bowel disease candidate gene
TLDR
There was no apparent evidence of SLC11A1 promoter allele association in the studied Crohn's disease population, and the results therefore refute previous studies that have shown SLC 11A 1 promoter polymorphisms are involved in susceptibility to this form of IBD.
Polymorphism at NRAMP1 and D2S1471 loci associated with juvenile rheumatoid arthritis.
TLDR
The NRAMP1 allele conferring susceptibility to JRA drives high levels ofNRAMP1 expression, while the allele associated with protection drives low levels, consistent with their maintenance in populations through balancing selection.
Inflammatory bowel disease is associated with a novel promoter polymorphism of natural resistance-associated macrophage protein 1 (NRAMP1) gene.
TLDR
The findings suggest that the novel promoter polymorphism of the NRAMP1 gene may influence susceptibility to IBD in the Japanese population.
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
TLDR
It is suggested that the NOD2 gene product confers susceptibility to Crohn's disease by altering the recognition of these components and/or by over-activating NF-kB in monocytes, thus documenting a molecular model for the pathogenic mechanism of Crohn’s disease that can now be further investigated.
Mycobacterium avium subsp. paratuberculosis, Genetic Susceptibility to Crohn's Disease, and Sardinians: the Way Ahead
TLDR
The results show that more than 70 percent of people in Sardinia with Crohn's disease carry at least one of the susceptibility-associated NOD2/CARD15 alleles and were infected with Mycobacterium avium subspecies paratuberculosis.
Identification of novel alleles at a polymorphic microsatellite repeat region in the human NRAMP1 gene promoter: analysis of allele frequencies in primary biliary cirrhosis
TLDR
NRAMP1 (natural resistance associated macrophage protein 1) was isolated as the human homologue of the mouse nramp1 gene which, when mutated, is responsible for susceptibility to a number of macrophages trophic intracellular pathogens including Mycobacterium bovis, Salmonella typhimurium , and Leishmania donovani.
Linkage of cytokine genes to rheumatoid arthritis. Evidence of genetic heterogeneity
TLDR
Weak evidence of linkage of RA to IL5R, IFNγ, and IL2 has been detected in clinical subsets of sibling pairs suggesting that RA is a genetically heterogeneous disease.
...
...